207 related articles for article (PubMed ID: 22970326)
1. Notch activation is dispensable for D, L-sulforaphane-mediated inhibition of human prostate cancer cell migration.
Hahm ER; Chandra-Kuntal K; Desai D; Amin S; Singh SV
PLoS One; 2012; 7(9):e44957. PubMed ID: 22970326
[TBL] [Abstract][Full Text] [Related]
2. Notch activation by phenethyl isothiocyanate attenuates its inhibitory effect on prostate cancer cell migration.
Kim SH; Sehrawat A; Sakao K; Hahm ER; Singh SV
PLoS One; 2011; 6(10):e26615. PubMed ID: 22039516
[TBL] [Abstract][Full Text] [Related]
3. Notch2 activation by benzyl isothiocyanate impedes its inhibitory effect on breast cancer cell migration.
Kim SH; Sehrawat A; Singh SV
Breast Cancer Res Treat; 2012 Aug; 134(3):1067-79. PubMed ID: 22476855
[TBL] [Abstract][Full Text] [Related]
4. D,L-Sulforaphane causes transcriptional repression of androgen receptor in human prostate cancer cells.
Kim SH; Singh SV
Mol Cancer Ther; 2009 Jul; 8(7):1946-54. PubMed ID: 19584240
[TBL] [Abstract][Full Text] [Related]
5. D,L-Sulforaphane-induced cell death in human prostate cancer cells is regulated by inhibitor of apoptosis family proteins and Apaf-1.
Choi S; Lew KL; Xiao H; Herman-Antosiewicz A; Xiao D; Brown CK; Singh SV
Carcinogenesis; 2007 Jan; 28(1):151-62. PubMed ID: 16920735
[TBL] [Abstract][Full Text] [Related]
6. Functional relevance of D,L-sulforaphane-mediated induction of vimentin and plasminogen activator inhibitor-1 in human prostate cancer cells.
Vyas AR; Singh SV
Eur J Nutr; 2014 Apr; 53(3):843-52. PubMed ID: 24092501
[TBL] [Abstract][Full Text] [Related]
7. Sulforaphane inhibits constitutive and interleukin-6-induced activation of signal transducer and activator of transcription 3 in prostate cancer cells.
Hahm ER; Singh SV
Cancer Prev Res (Phila); 2010 Apr; 3(4):484-94. PubMed ID: 20233902
[TBL] [Abstract][Full Text] [Related]
8. Withaferin A causes activation of Notch2 and Notch4 in human breast cancer cells.
Lee J; Sehrawat A; Singh SV
Breast Cancer Res Treat; 2012 Nov; 136(1):45-56. PubMed ID: 22965833
[TBL] [Abstract][Full Text] [Related]
9. Sulforaphane-induced cell death in human prostate cancer cells is initiated by reactive oxygen species.
Singh SV; Srivastava SK; Choi S; Lew KL; Antosiewicz J; Xiao D; Zeng Y; Watkins SC; Johnson CS; Trump DL; Lee YJ; Xiao H; Herman-Antosiewicz A
J Biol Chem; 2005 May; 280(20):19911-24. PubMed ID: 15764812
[TBL] [Abstract][Full Text] [Related]
10. Induction of p21 protein protects against sulforaphane-induced mitotic arrest in LNCaP human prostate cancer cell line.
Herman-Antosiewicz A; Xiao H; Lew KL; Singh SV
Mol Cancer Ther; 2007 May; 6(5):1673-81. PubMed ID: 17513615
[TBL] [Abstract][Full Text] [Related]
11. Suppression of NF-kappaB and NF-kappaB-regulated gene expression by sulforaphane and PEITC through IkappaBalpha, IKK pathway in human prostate cancer PC-3 cells.
Xu C; Shen G; Chen C; Gélinas C; Kong AN
Oncogene; 2005 Jun; 24(28):4486-95. PubMed ID: 15856023
[TBL] [Abstract][Full Text] [Related]
12. Targeting cell cycle machinery as a molecular mechanism of sulforaphane in prostate cancer prevention.
Wang L; Liu D; Ahmed T; Chung FL; Conaway C; Chiao JW
Int J Oncol; 2004 Jan; 24(1):187-92. PubMed ID: 14654956
[TBL] [Abstract][Full Text] [Related]
13. Involvement of c-Jun N-terminal kinase in G2/M arrest and caspase-mediated apoptosis induced by sulforaphane in DU145 prostate cancer cells.
Cho SD; Li G; Hu H; Jiang C; Kang KS; Lee YS; Kim SH; Lu J
Nutr Cancer; 2005; 52(2):213-24. PubMed ID: 16201852
[TBL] [Abstract][Full Text] [Related]
14. Sulforaphane induces caspase-mediated apoptosis in cultured PC-3 human prostate cancer cells and retards growth of PC-3 xenografts in vivo.
Singh AV; Xiao D; Lew KL; Dhir R; Singh SV
Carcinogenesis; 2004 Jan; 25(1):83-90. PubMed ID: 14514658
[TBL] [Abstract][Full Text] [Related]
15. Cellular responses to cancer chemopreventive agent D,L-sulforaphane in human prostate cancer cells are initiated by mitochondrial reactive oxygen species.
Xiao D; Powolny AA; Antosiewicz J; Hahm ER; Bommareddy A; Zeng Y; Desai D; Amin S; Herman-Antosiewicz A; Singh SV
Pharm Res; 2009 Jul; 26(7):1729-38. PubMed ID: 19384467
[TBL] [Abstract][Full Text] [Related]
16. Reversal of the Warburg phenomenon in chemoprevention of prostate cancer by sulforaphane.
Singh KB; Hahm ER; Alumkal JJ; Foley LM; Hitchens TK; Shiva SS; Parikh RA; Jacobs BL; Singh SV
Carcinogenesis; 2019 Dec; 40(12):1545-1556. PubMed ID: 31555797
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of sulforaphane on histone deacetylases, cell cycle arrest and apoptosis in normal prostate cells versus hyperplastic and cancerous prostate cells.
Clarke JD; Hsu A; Yu Z; Dashwood RH; Ho E
Mol Nutr Food Res; 2011 Jul; 55(7):999-1009. PubMed ID: 21374800
[TBL] [Abstract][Full Text] [Related]
18. Sulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cells.
Myzak MC; Hardin K; Wang R; Dashwood RH; Ho E
Carcinogenesis; 2006 Apr; 27(4):811-9. PubMed ID: 16280330
[TBL] [Abstract][Full Text] [Related]
19. Sulforaphane and its metabolite mediate growth arrest and apoptosis in human prostate cancer cells.
Chiao JW; Chung FL; Kancherla R; Ahmed T; Mittelman A; Conaway CC
Int J Oncol; 2002 Mar; 20(3):631-6. PubMed ID: 11836580
[TBL] [Abstract][Full Text] [Related]
20. Prostate cancer chemoprevention by sulforaphane in a preclinical mouse model is associated with inhibition of fatty acid metabolism.
Singh KB; Kim SH; Hahm ER; Pore SK; Jacobs BL; Singh SV
Carcinogenesis; 2018 May; 39(6):826-837. PubMed ID: 29668854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
